Spinocerebellar Ataxia Type 23

Neurology·MeSH: Rectal Fistula

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinocerebellar Ataxia Type 23?

There are 1 clinical trial targeting Spinocerebellar Ataxia Type 23 tracked by BioSniper.

What is the prevalence of Spinocerebellar Ataxia Type 23?

The estimated prevalence of Spinocerebellar Ataxia Type 23 is approximately 0.1 per 100,000 population.

Deep-dive into Spinocerebellar Ataxia Type 23

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinocerebellar Ataxia Type 23 — Drugs in Development & Clinical Trials | BioSniper